Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 11Prostatic Neoplasms 9Breast Neoplasms 9Leukemia, Myeloid, Acute 8Leukemia, Lymphocytic, Chronic, B-Cell 7Neuroblastoma 6Myelodysplastic Syndromes 6Multiple Myeloma 6Melanoma 6Lymphoma 6Glioblastoma 6Ovarian Neoplasms 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Glioma 4Osteosarcoma 3Neoplasm Metastasis 3Lymphoma, Non-Hodgkin 3Kidney Neoplasms 3Fallopian Tube Neoplasms 3Breast Neoplasms, Male 3Neoplasms, Plasma Cell 2Neoplasms 2Medulloblastoma 2Hodgkin Disease 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Wilms Tumor 1Uveal Melanoma 1Urinary Bladder Neoplasms 1

Interventions

Tacrolimus 29fludarabine phosphate 21Methotrexate 21Cyclophosphamide 21Mycophenolic Acid 18Busulfan 15Antilymphocyte Serum 14Whole-Body Irradiation 13Sirolimus 12fludarabine 11Peripheral Blood Stem Cell Transplantation 11Cyclosporine 9thymoglobulin 8Melphalan 8Hematopoietic Stem Cell Transplantation 6Granulocyte Colony-Stimulating Factor 6Filgrastim 6Rituximab 5Pentostatin 5Methylprednisolone 5Thiotepa 4Stem Cell Transplantation 4Radiotherapy 4Cyclosporins 4ruxolitinib 3Vorinostat 3Transplantation 3Flow Cytometry 3Etoposide 3merphos 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Graft vs Host Disease × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00429416 2016-11-29

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Thomas Jefferson University

Phase 1/2 Completed
14 enrolled 11 charts
Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡